Philippe Tramoy graduated in biochemistry and in immunology and genetics from the University of Burgundy and the École Normale Supérieure de Lyon, the IAE Paris Panthéon-Sorbonne (Master in Finance) and HEC Paris (Master in Intelligence Marketing) . A specialist in the world of biotech, working with Rhodia Corporate, Rhodia Chirex and Rhodia Pharma Solutions, in 2004 he founded CBDMT, a market and business intelligence company. Since 2013, he has been Director of Investments for the Quadrivium 1 Seed Fund of Seventure Partners.
Current role